Exane Derivatives’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,128
| Closed | -$96.2K | – | 1029 |
|
|
2022
Q1 | $96.2K | Buy |
+1,128
| New | +$96.2K | 0.03% | 477 |
|
|
2021
Q4 | – | Sell |
-3,545
| Closed | -$438K | – | 1066 |
|
|
2021
Q3 | $438K | Sell |
3,545
-18
| -0.5% | -$2.23K | 0.11% | 201 |
|
|
2021
Q2 | $430K | Buy |
3,563
+917
| +35% | +$111K | 0.1% | 210 |
|
|
2021
Q1 | $278K | Sell |
2,646
-1,143
| -30% | -$120K | 0.08% | 231 |
|
|
2020
Q4 | $386K | Buy |
3,789
+3,780
| +42,000% | +$385K | 0.11% | 208 |
|
|
2020
Q3 | $757 | Hold |
9
| – | – | ﹤0.01% | 617 |
|
|
2020
Q2 | $585 | Hold |
9
| – | – | ﹤0.01% | 578 |
|
|
2020
Q1 | $586 | Hold |
9
| – | – | ﹤0.01% | 557 |
|
|
2019
Q4 | $742 | Hold |
9
| – | – | ﹤0.01% | 547 |
|
|
2019
Q3 | $716 | Hold |
9
| – | – | ﹤0.01% | 531 |
|
|
2019
Q2 | $753 | Sell |
9
-1
| -10% | -$84 | ﹤0.01% | 545 |
|
|
2019
Q1 | $790 | Sell |
10
-1,804
| -99% | -$143K | ﹤0.01% | 489 |
|
|
2018
Q4 | $121K | Hold |
1,814
| – | – | 0.02% | 275 |
|
|
2018
Q3 | $146K | Sell |
1,814
-5
| -0.3% | -$403 | 0.03% | 260 |
|
|
2018
Q2 | $122K | Buy |
1,819
+13
| +0.7% | +$874 | 0.02% | 286 |
|
|
2018
Q1 | $137K | Sell |
1,806
-22,672
| -93% | -$1.72M | 0.03% | 250 |
|
|
2017
Q4 | $1.67M | Buy |
24,478
+23,004
| +1,561% | +$1.57M | 0.29% | 50 |
|
|
2017
Q3 | $92.3K | Sell |
1,474
-242
| -14% | -$15.2K | 0.02% | 249 |
|
|
2017
Q2 | $95.1K | Sell |
1,716
-19,226
| -92% | -$1.07M | 0.02% | 245 |
|
|
2017
Q1 | $1.05M | Buy |
+20,942
| New | +$1.05M | 0.24% | 81 |
|